Kory James Wentworth - Net Worth and Insider Trading
Kory James Wentworth Net Worth
The estimated net worth of Kory James Wentworth is at least $1 Million dollars as of 2024-12-26. Kory James Wentworth is the CFO of Entrada Therapeutics Inc and owns about 73,849 shares of Entrada Therapeutics Inc (TRDA) stock worth over $1 Million. Kory James Wentworth is also the Principal Accounting Officer of bluebird bio Inc and owns about 476 shares of bluebird bio Inc (BLUE) stock worth over $4,179. Details can be seen in Kory James Wentworth's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kory James Wentworth has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kory James Wentworth
Kory James Wentworth Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kory James Wentworth owns 2 companies in total, including bluebird bio Inc (BLUE) , and Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of Kory James Wentworth’s form 4 insider trades.
Insider Ownership Summary of Kory James Wentworth
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLUE | bluebird bio Inc | 2020-08-03 | Principal Accounting Officer |
| TRDA | Entrada Therapeutics Inc | 2024-12-02 | Chief Financial Officer |
Kory James Wentworth Latest Holdings Summary
Kory James Wentworth currently owns a total of 2 stocks. Among these stocks, Kory James Wentworth owns 73,849 shares of Entrada Therapeutics Inc (TRDA) as of December 2, 2024, with a value of $1 Million and a weighting of 99.68%. Kory James Wentworth also owns 476 shares of bluebird bio Inc (BLUE) as of August 3, 2020, with a value of $4,179 and a weighting of 0.32%.
Latest Holdings of Kory James Wentworth
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics Inc | 2024-12-02 | 73,849 | 17.76 | 1,311,831 |
| BLUE | bluebird bio Inc | 2020-08-03 | 476 | 8.78 | 4,179 |
Holding Weightings of Kory James Wentworth
Kory James Wentworth Form 4 Trading Tracker
According to the SEC Form 4 filings, Kory James Wentworth has made a total of 15 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in Entrada Therapeutics Inc is the sale of 6,000 shares on December 2, 2024, which brought Kory James Wentworth around $119,940.
According to the SEC Form 4 filings, Kory James Wentworth has made a total of 4 transactions in bluebird bio Inc (BLUE) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in bluebird bio Inc is the sale of 4 shares on August 3, 2020, which brought Kory James Wentworth around $5,002.
Insider Trading History of Kory James Wentworth
- 1
Kory James Wentworth Trading Performance
Kory James Wentworth Ownership Network
Kory James Wentworth Owned Company Details
What does bluebird bio Inc do?
Who are the key executives at bluebird bio Inc?
Kory James Wentworth is the Principal Accounting Officer of bluebird bio Inc. Other key executives at bluebird bio Inc include Chief Medical Officer Richard A Colvin , President of SGD Andrew Obenshain , and Chief Commercial Officer & SGD Thomas J Klima .
bluebird bio Inc (BLUE) Insider Trades Summary
Over the past 18 months, Kory James Wentworth made no insider transaction in bluebird bio Inc (BLUE). Other recent insider transactions involving bluebird bio Inc (BLUE) include a net sale of 29,843 shares made by Andrew Obenshain , a net sale of 12,534 shares made by Richard A Colvin , and a net sale of 12,043 shares made by Thomas J Klima .
In summary, during the past 3 months, insiders sold 190 shares of bluebird bio Inc (BLUE) in total and bought 0 shares, with a net sale of 190 shares. During the past 18 months, 3,208 shares of bluebird bio Inc (BLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,208 shares.
bluebird bio Inc (BLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
bluebird bio Inc Insider Transactions
Kory James Wentworth Mailing Address
Above is the net worth, insider trading, and ownership report for Kory James Wentworth. You might contact Kory James Wentworth via mailing address: 6 Tide Street, C/o Entrada Therapeutics, Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
